Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Elastographic Evaluation Be a New Approach in Prediction of Endometrial Cancer Prognostic Markers?

NCT06623916 is registered in ClinicalTrials.gov with Alper seyhan as lead sponsor.

NCT NCT06623916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06623916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Elastographic Evaluation Be a New Approach in Prediction of Endometrial Cancer Prognostic Markers?
Lead sponsor
Alper seyhan
Phase
Observational
Overall status
Completed
Start date
December 1, 2022
Completion date
July 1, 2023
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer